
    
      This trial has several objectives:

      Primary Objective To determine which combination (dose-ratio) of dextromethorphan and
      lidocaine provides the best balance of pain reduction and toxicity.

      Secondary Objectives include To evaluate the analgesic efficacy of both dextromethorphan and
      lidocaine in attenuating pain related to central nervous system sensitization, specifically
      spontaneous pain, mechanical allodynia, and hyperalgesia.
    
  